Central Nervous System Regulation of Food Intake
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Some 50 years ago, Gordon Kennedy introduced the hypothesis that body fat stores are subject to homeostatic regulation through a process in which afferent signals generated in proportion to body fat mass provide negative feedback to brain areas involved in the control of food intake (1). He further proposed that the central nervous system response to this input is fundamentally catabolic in nature, being characterized by decreased food intake, increased energy expenditure, and weight loss. Accordingly, weight gain caused by a period of excessive food consumption is hypothesized to increase the delivery of "adiposity negative feedback" signals to the brain. This response in turn induces a state of negative energy balance (i.e., energy intake less than energy expenditure) that persists until excess body fat is dissipated, at which point both food intake and body weight return to their original, preintervention levels. Conversely, the effect of energy restriction to reduce body fat stores is predicted to reduce adiposity-related negative feedback to the brain. This response triggers a compensatory increase in the drive to eat that, combined with decreased metabolic rate, favors the recovery of depleted fat stores when food becomes available. The importance of this model lies not only in the light that it sheds on the mechanisms underlying energy homeostasis in normal weight individuals but in the framework it provides for studying obesity as a disorder of a regulated system rather than as the consequence of a lack of restraint or will power. Another attractive feature of this model is that it lends itself to critical hypothesis testing. For example, it predicts that genetic or acquired defects in neuronal sensing or responsiveness to input from adiposity-related signals should be interpreted by the brain as a deficit of body energy stored in the form of fat. In response, hyperphagia, reduced metabolic rate, and pathological expansion of body fat mass should occur. Evidence in support of this prediction first emerged from studies using a technique known as "parabiosis." In this paradigm, two experimental animals are surgically joined to one another, allowing a shared circulation to develop. With this strategy, Coleman showed that food intake and body weight of genetically obese mice (ob/ob) decrease when they were parabiosed to lean controls and that this weight loss was even more pronounced when they were parabiosed to mice with a different monogenic form of obesity (db/db) (2). From these observations, he inferred that ob/ob mice are obese because they lack a key adiposity negative feedback signal, whereas db/db make this signal (and hence reduce the body weight of parabiosed ob/ob partners) but are obese because they cannot respond to it. Both predictions were realized some 20 years later with the positional cloning of the ob gene locus in 1994 (3) and the demonstration that it encodes the adipocyte hormone, leptin. In this landmark paper, ob/ob mice were also shown to be homozygous for a point mutation that results in a biologically inactive leptin molecule. Thus, severe hyperphagia and obesity in ob/ob mice was hypothesized to arise from leptin deficiency, and indeed, leptin administration was subsequently shown to reverse this obesity phenotype (4, 5). Two years later, the leptin receptor was cloned (6), and the obese phenotype of db/db mice was shown to arise from a mutation in the leptin receptor gene. Together, these findings showed that genetic deficiency of either leptin or its receptor is sufficient to induce a severe obesity phenotype in mice. Combined with evidence that leptin circulates at levels proportionate to body fat stores, that it enters the brain from the circulation, that leptin receptors are expressed in brain areas associated with control of food intake and autonomic function, and that leptin administration directly into the brain potently reduces food intake and body weight (7), Kennedy's model of energy homeostasis, once viewed with understandable skepticism, was rapidly and widely accepted. The intense interest in the biology of energy homeostasis sparked by these and many subsequent findings has yielded an increasingly sophisticated understanding of its underlying mechanisms. Additional hormonal and nutrient-related signals have been identified that convey important afferent information to the brain, and the specific subsets of neurons on which they act are beginning to be identified. Similarly, mechanisms linking the response of these neurons to changes of feeding behavior and autonomic nervous system function, and the relevance of this basic information to clinical obesity, are beginning to be appreciated. Especially important is evidence that genetic deficiency of either leptin (8) or its receptor (9) cause a severe obesity phenotype in humans reminiscent of that observed in mice and that leptin-deficient humans (like ob/ob mice) exhibit a dramatic normalization of this phenotyp
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479 · cited 2×
“Ghrelin, Peptide YY3–36, and the ARC In addition to input from insulin and leptin, the ARC also senses changes in energy balance conveyed by the gastric hormone ghrelin (27) and the intestinal hormone, peptide YY3–36 (PYY3–36) (28).”
BackgroundCentral nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · cited 4×
“Conversely, the effect of weight loss to lower plasma insulin and leptin levels, and thereby reduce neuronal input from these two hormones, is proposed to activate NPY/AgRP neurons (24,25) and thereby stimulate food intake (7,25).”
BackgroundInfluentialSelf-citationSerum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese Humans
Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340503 · Cited by 6,326
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501 · cited 1×
“regulation are those that express either orexin (41) or mel-”
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 2×
“Neuronal Signal Transduction Elicited by Adiposity-related Hormones As in peripheral tissues (46), neuronal activation of the insulin receptor, a tyrosine kinase and member of the growth factor receptor family, induces the recruitment and tyrosine phosphorylation of insulin-receptor substrate (IRS) proteins (47).”
BackgroundEffects of the obese Gene Product on Body Weight Regulation in ob / ob Mice
Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., & Collins, F. (1995) · Science · doi:10.1126/science.7624776 · Cited by 4,017
Identification and expression cloning of a leptin receptor, OB-R.
Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90151-5 · Cited by 3,496
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443 · cited 1×
“By activating its receptor on NPY/ AgRP neurons, ghrelin stimulates food intake and is the only known circulating hormone to exert this effect (29).”
BackgroundCampfield, L. A., Smith, F. J., Guisez, Y., Devos, R., & Burn, P. (1995) · Science · doi:10.1126/science.7624778 · Cited by 3,243 · cited 1×
“Thus, severe hyperphagia and obesity in ob/ob mice was hypothesized to arise from leptin deficiency, and indeed, leptin administration was subsequently shown to reverse this obesity phenotype (4,5).”
BackgroundTargeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 1×
“Conversely, pharmacological or genetic disruption of Mc4r signaling causes hyperphagia and obesity (17,18) and prevents or attenuates the weight-reducing actions of centrally administered insulin (16) or leptin (19).”
Background
Cited by
Mechanisms of leptin action and leptin resistance.
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100707 · Cited by 1,074
“AgRP is an antagonist of αMSH/MC4R signaling as well as an inhibitor (inverse agonist) of endogenous MC4R activity (36, 38).”
BackgroundCentral Control of Body Weight and Appetite
Woods, S. C., & D'Alessio, D. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1630 · Cited by 458
Central nervous system control of metabolism
Myers, M. G., & Olson, D. P. (2012) · Nature · doi:10.1038/nature11705 · Cited by 399
Ravussin, E., Smith, S. R., Mitchell, J. A., Shringarpure, R., Shan, K., Maier, H., Koda, J. E., & Weyer, C. (2009) · Obesity · doi:10.1038/oby.2009.184 · Cited by 332
Toll-like receptors: linking inflammation to metabolism
Könner, A. C., & Brüning, J. C. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.08.007 · Cited by 331
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Corbin, K. D., Driscoll, K. A., Pratley, R. E., Smith, S. R., Maahs, D. M., Mayer-Davis, E. J., & Advancing Care for Type 1 Diabetes and Obesity Network (ACT1ON) (2018) · Endocrine Reviews · doi:10.1210/er.2017-00191 · Cited by 262
Intense sweeteners, energy intake and the control of body weight.
Bellisle, F., & Drewnowski, A. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602649 · Cited by 200
“dense diets cause insulin and leptin resistance in the central nervous system (CNS) (Schwartz, 2006) and blunt responses to”
BackgroundSex-based differences in the behavioral and neuronal responses to food
Cornier, M.-A., Salzberg, A. K., Endly, D. C., Bessesen, D. H., & Tregellas, J. R. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.01.008 · Cited by 196
Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis
Könner, A. C., Hess, S., Tovar, S., Mesaros, A., Sánchez-Lasheras, C., Evers, N., Verhagen, L. A. W., Brönneke, H. S., Kleinridders, A., Hampel, B., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.021 · Cited by 194
Effects of overfeeding on the neuronal response to visual food cues
Cornier, M.-A., Von Kaenel, S. S., Bessesen, D. H., & Tregellas, J. R. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.965 · Cited by 160
The effects of exercise on the neuronal response to food cues
Cornier, M.-A., Melanson, E. L., Salzberg, A. K., Bechtell, J. L., & Tregellas, J. R. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.11.023 · Cited by 144
Weigt, C., Hertrampf, T., Zoth, N., Fritzemeier, K. H., & Diel, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.12.013 · Cited by 56
Acquired hypothalamic obesity: A clinical overview and update
Roth, C. L., & McCormack, S. E. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15530 · Cited by 42
“14,15 An overview of major hunger-stimulating and inhibiting peripheral peptides and metabolites is provided in Table 2.”
BackgroundDornellas, A. P. S., Watanabe, R. L. H., Pimentel, G. D., Boldarine, V. T., Nascimento, C. M. O., Oyama, L. M., Ghebremeskel, K., Wang, Y., Bueno, A. A., & Ribeiro, E. B. (2015) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.10.003 · Cited by 18
Metadata
- Authors
- Schwartz, M. W.
- Venue
- Obesity
- Publisher
- Wiley
- Published
- 2006-02
- Volume
- 14
- Issue
- S2
- Pages
- 1S-8S
- ISSN
- 1930-7381 (ISSN-L)
- 1930-739X
- OpenAlex
- W2166947492
- Cited by
- 145
- References
- 41
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.